T3d Therapeutics Inc Headquarters
The links below provide all the necessary information about T3d Therapeutics Inc Headquarters. Also there you will find information about the address, phone numbers, emails and much more.
T3D Therapeutics | T3D Therapeutics
- http://www.t3dtherapeutics.com/
- Welcome to T3D Therapeutics. T3D Therapeutics, Inc. was founded in 2013 to challenge the prevailing thinking over the last two decades in the development of solutions to effectively treat Alzheimer’s disease. Our mission is to develop a ground-breaking, disease-modifying, new drug for the treatment of Alzheimer’s disease (AD).
Contact Us | T3D Therapeutics
- http://www.t3dtherapeutics.com/contact-us/
- Thank you for visiting T3D Therapeutics. If you would like to contact us, please use the contact form to the left and we will contact you shortly. Address: 68 T.W. Alexander Drive PO Box 13628 Research Triangle Park, NC 27709. Phone: 919-237-4897. Fax: 919-558-0365
About Us | T3D Therapeutics
- http://www.t3dtherapeutics.com/about-us/
- A Transformational Approach to Treating Alzheimer’s Disease … and more. T3D Therapeutics’ mission is to develop its lead drug product candidate, T3D-959, as a potential ‘First-in-Class’ and ‘Best-in-Class’ disease-modifying, breakthrough medicine for the treatment of Alzheimer’s disease, a drug with the potential to slow, stop or reverse the course of the disease.
T3D Therapeutics - Crunchbase Company Profile & Funding
- https://www.crunchbase.com/organization/t3d-therapeutics
- Legal Name T3D Therapeutics Inc. Company Type For Profit. Contact Email [email protected]. Phone Number 919-237-4897. T3D Therapeutics is a developer of a novel drug therapy intended to stop or reverse the course of Alzheimer's disease. The company's drug is an orally-delivered once-a-day medicine that targets both the brain 'starvation ...
T3D Therapeutics Inc. | North Carolina Biotech Center
- https://directory.ncbiotech.org/company/t3d-therapeutics-inc
- T3D Therapeutics Inc. T3D Therapeutics is developing a disease-modifying drug therapy for Alzheimer’s disease that may improve multiple disease defects. T3D is also targeting treatments for other neurodegenerative diseases including Huntington's Disease. Company Location. https://www.t3dtherapeutics.com. 68 T.W. Alexander Drive.
T3D Therapeutics, Inc. | LinkedIn
- https://www.linkedin.com/company/t3d-therapeutics-inc.
- Headquarters Durham, North Carolina Type Privately Held Locations Primary 68 T W Alexander Drive ... T3D Therapeutics, Inc. | 117 followers on LinkedIn. Developing a …
T3D Therapeutics - Overview, News & Competitors
- https://www.zoominfo.com/c/t3d-therapeutics-inc/359488263
- T3D Therapeutics, Inc. is a privately-held, Research Triangle Park, NC-based company. The Company has an exclusive license to T3D-959, its lead product candidat. e, and a platform of structurally-related molecules. T3D Therapeutics' mission is to develop and commercialize T3D-959 for the treatment of Alzheimer's disease and Mild Cognitive ...
T3D Therapeutics Company Profile: Valuation & Investors …
- https://pitchbook.com/profiles/company/58352-95
- Information on valuation, funding, cap tables, investors, and executives for T3D Therapeutics. Use the PitchBook Platform to explore the full profile.
T3D Therapeutics Inc. - Company Profiles - BCIQ
- https://profiles.biocentury.com/companies/t3d_therapeutics_inc
- For the biopharma industry investment, business development and competitive intelligence professionals who require information to support financing, partnering and licensing activities, BCIQ provides accurate information and context to support profitable and strategic decision making. Unlike other intelligence solutions, BCIQ exclusively supports the unique needs of the …
Mission | T3D Therapeutics
- http://www.t3dtherapeutics.com/about-us/mission/
- T3D Therapeutics’ mission is to develop its lead drug product candidate, T3D-959, as a potential ‘First-in-Class’ and ‘Best-in-Class’ disease-modifying, breakthrough medicine for the treatment of Alzheimer’s disease with the potential to slow, stop or reverse the course of the disease. ... T3D-959 is a PPAR delta agonist with lesser ...
T3D Therapeutics Inc | Research Triangle Park - RTP
- https://www.rtp.org/company/t3d-therapeutics-inc/
- Biotechnology + Life Sciences. T3D Therapeutics’ mission, as a pharmaceutical R&D company, is to develop and commercialize T3D-959, potentially an optimal disease remedial therapeutic for the treatment of Alzheimer’s Disease. Unlike single dimension therapies in development that target one abnormality (i.e. pathology), for example beta ...
News + Events | T3D Therapeutics
- http://www.t3dtherapeutics.com/news-events/
- A New Approach to Treating Alzheimer’s Disease Receives Major NIA Backing. Research Triangle Park, NC, May 20, 2019 — T3D Therapeutics, a clinical stage drug development company engaged in the development of T3D-959 (the “Company”), a new orally administered treatment for Alzheimer’s disease (AD), announced today that it has received ...
Research Triangle Park's T3D Therapeutics raises $15 million …
- https://www.bizjournals.com/triangle/news/2019/11/04/rtp-drugmaker-raises-15m-as-it-moves-forward-with.html
- T3D Therapeutics is based around the development of its lead candidate – T3D-959 – an orally administered treatment for Alzheimer's. The drug is currently in a Phase 2 study, and the company ...
t3d therapeutics Company Overview - definitions.net
- https://www.definitions.net/definition/t3d%20therapeutics
- Company overview of t3d therapeutics from the Definitions.net dictionary. Detailed information of t3d therapeutics in the most comprehensive reference resource on …
Did you find out everything you wanted about T3d Therapeutics Inc Headquarters?
We are sure that the information collected for you about T3d Therapeutics Inc Headquarters turned out to be more than enough.
